ClinicalTrials.gov record
Completed Phase 2 Interventional

Antiviral Activity of and Resistance to Lamivudine in Combination With Zidovudine, Stavudine, or Didanosine

ClinicalTrials.gov ID: NCT00000838

Public ClinicalTrials.gov record NCT00000838. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 7:17 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II, Randomized Study of the Antiviral Activity and Resistance Interactions of Lamivudine (3TC) in Combination With Zidovudine (AZT), Stavudine (d4T), or Didanosine (ddI) Versus Monotherapy With ddI or d4T in HIV-Infected Individuals With 200 - 600 CD4+ Cells/mm3 and No Previous Nucleoside Experience

Study identification

NCT ID
NCT00000838
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Enrollment
256 participants

Conditions and interventions

Conditions

Interventions

  • Didanosine Drug
  • Lamivudine Drug
  • Stavudine Drug
  • Zidovudine Drug

Drug

Eligibility (public fields only)

Age range
12 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Not listed
Completion
Feb 28, 1998
Last update posted
Nov 3, 2021

Ends 1998

United States locations

U.S. sites
31
U.S. states
15
U.S. cities
24
Facility City State ZIP Site status
Alabama Therapeutics CRS Birmingham Alabama
UCLA CARE Center CRS Los Angeles California 90095
Stanford CRS Palo Alto California 94115
Ucsd, Avrc Crs San Diego California 92103
Santa Clara Valley Med. Ctr. San Jose California 95128
San Mateo County AIDS Program San Mateo California
University of Colorado Hospital CRS Aurora Colorado 80262
Univ. of Miami AIDS CRS Miami Florida 33136
Queens Med. Ctr. Honolulu Hawaii 96816
Univ. of Hawaii at Manoa, Leahi Hosp. Honolulu Hawaii 96816
Cook County Hosp. CORE Ctr. Chicago Illinois 60612
Rush Univ. Med. Ctr. ACTG CRS Chicago Illinois 60612
Weiss Memorial Hosp. Chicago Illinois 60640
Northwestern University CRS Chicago Illinois
Indiana Univ. School of Medicine, Infectious Disease Research Clinic Indianapolis Indiana 46202
Methodist Hosp. of Indiana Indianapolis Indiana 46202
Johns Hopkins Adult AIDS CRS Baltimore Maryland 21287
Beth Israel Deaconess Med. Ctr., ACTG CRS Boston Massachusetts
St. Louis ConnectCare, Infectious Diseases Clinic St Louis Missouri 63112
Washington U CRS St Louis Missouri
SUNY - Buffalo, Erie County Medical Ctr. Buffalo New York 14215
Beth Israel Med. Ctr. (Mt. Sinai) New York New York 10003
NYU Med. Ctr., Dept. of Medicine New York New York 10016
Univ. of Rochester ACTG CRS Rochester New York
Unc Aids Crs Chapel Hill North Carolina
Carolinas HealthCare System, Carolinas Med. Ctr. Charlotte North Carolina
Regional Center for Infectious Disease, Wendover Medical Center CRS Greensboro North Carolina
MetroHealth CRS Cleveland Ohio 44109
The Ohio State University Medical Center Columbus Ohio 43210
Hosp. of the Univ. of Pennsylvania CRS Philadelphia Pennsylvania 19104
University of Washington AIDS CRS Seattle Washington 98122

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00000838, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 3, 2021 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00000838 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →